HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Hall, I. P. Articles by Sayers, I. Search for Related Content PubMed PubMed Citation Articles by Hall, I. P. Articles by Sayers, I.

Pharmacogenetics and asthma: false hope or new dawn?

Division of Therapeutics and Molecular Medicine, University Hospital of Nottingham, Nottingham, UK.

CORRESPONDENCE: I. P. Hall, Division of Therapeutics and Molecular Medicine, University Hospital of Nottingham, Nottingham, NG7 2UH, UK. Fax: 44 1158754596. E-mail: ian.hall{at}nottingham.ac.uk

Keywords: Asthma genetics

Received: July 3, 2006
Accepted October 25, 2006

Pharmacogenetic approaches provide the opportunity to improve prescribing for asthmatic patients in order to optimise efficacy and prevent side-effects. Currently, there are comprehensive data available on the extent of genetic variation in the human genome that will further this area of research. However, less is known about the functional consequences of many of the identified polymorphisms in genes whose products may predict drug efficacy. In addition, there is a shortage of well-designed, adequately powered clinical studies in this area. This series summarises the current state of knowledge and identifies areas for further research.